MyAverix Finance MyAverix Finance

LSE · Healthcare

International Biotechnology Trust plc (IBT)

Biotechnology

International Biotechnology Trust plc (IBT) is listed on LSE in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-23

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for IBT

P/E ratio
18.00

International Biotechnology Trust plc (IBT) — FAQ

What is IBT's P/E ratio?

The price-to-earnings (P/E) ratio for International Biotechnology Trust plc (IBT) is 18.00 (data as of 2026-03-23).

Does International Biotechnology Trust plc pay a dividend?

Dividend yield is not available in the current snapshot for International Biotechnology Trust plc (IBT). Check the MyAverix Finance app for the latest dividend data.

What sector is International Biotechnology Trust plc in?

International Biotechnology Trust plc (IBT) is classified in the Healthcare sector (Biotechnology industry).

What exchange is IBT listed on?

IBT is listed on LSE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play